BioCity Nottingham

From Wikipedia, the free encyclopedia

BioCity Nottingham
Bio City Nottingham (2) - geograph.org.uk - 948646.jpg
Biocity buildings
FormationSeptember 2003
Legal statusScience park
PurposeBioscience innovation
Location
  • Pennyfoot Street, Nottingham, NG1 1GF
Region served
UK
Membership
70 companies
Chief Executive
Dr Glenn Crocker
Main organ
BioCity Board (Chairman – Dr Louis Nisbet)
AffiliationsNottingham Trent University, University of Nottingham,
WebsiteBioCity

BioCity Nottingham is a bioscience science park in central Nottingham in the United Kingdom. It is the UK's largest bioscience innovation and incubation centre.

History[]

In 2002, laboratories and office space were donated to Nottingham Trent University by BASF. Biocity was founded in September 2003 by the University of Nottingham, Nottingham Trent University (NTU) and the East Midlands Development Agency (which was based close to BioCity).

Biocity's premises were developed from the building donated by BASF. Phase 1 was completed in March 2004, providing 36,000 sq ft (3,300 m2) of space, then Phase 2 in March 2006 provided 24,000 sq ft (2,200 m2). When Phase 3 of the development was completed in October 2008, with 45,000 sq ft (4,200 m2), funding from emda also finished.

Background[]

Nottingham has a history of bioscience research done at the University of Nottingham, Nottingham Trent University and by Boots, Britain's largest retail pharmacy company, which is based in Dunkirk/Beeston.[1]

The Royal Society of Chemistry blue plaque at BioCity

Although Boots no longer engages in drug discovery, Ibuprofen (iso-butyl-propanoic-phenolic acid) was created by a team of Boots scientists including Stewart Adams and .[2] In November 2013 work on ibuprofen was recognised by the erection of a Royal Society of Chemistry blue plaque on the site of the original laboratory where the painkiller was developed. The plaque reads:[3]

In recognition of the pioneering research work, here on Pennyfoot Street, by Dr Stewart Adams and Dr John Nicholson in the Research Department of Boots which led to the discovery of ibuprofen used by millions worldwide for the relief of pain.

In March 2005 Nottingham was named as a Science City; the other 5 Science Cities were Birmingham,[4] Bristol, York, Newcastle[5] and Manchester.

Structure[]

It is situated in former BASF buildings, which previously were used by Boots as research laboratories. The site on Pennyfoot Street, between the A60 and A612, is for bioscience SMEs. The University of Nottingham has the largest collaboration with companies at BioCity, with a few having links with NTU.

There are three buildings –

  • Innovation Centre Building
  • Stewart Adams Building – named after Dr Stewart Adams OBE, who led the team at Boots (with John Nicholson) that discovered Ibuprofen, a non-steroidal anti-inflammatory drug, in 1963[6]
  • Laurus Building

In January 2012 BioCity opened a second site, BioCity Scotland, resulting from the acquisition of a former MSD research facility near Glasgow.

See also[]

References[]

  1. ^ Matthew Bunn (11 February 2019). "New £8m medical technology hub proposed for Boots' Enterprise Zone site". Nottinghamshire Live. Retrieved 25 June 2019.
  2. ^ Boots ibuprofen project Archived 1 October 2012 at the Wayback Machine
  3. ^ "Chemical landmark plaque honours scientific discovery past and future". Royal Society of Chemistry News.
  4. ^ "About Us at Birmingham Science City". Archived from the original on 14 July 2011. Retrieved 21 July 2011.
  5. ^ Newcastle Science City Archived 17 July 2011 at the Wayback Machine
  6. ^ Dr Stewart Adams

External links[]

News items[]

Video clips[]

Coordinates: 52°57′04″N 1°8′11″W / 52.95111°N 1.13639°W / 52.95111; -1.13639

Retrieved from ""